Gary Harms shops for Roundup products at a store in San Rafael, California, on July, 9, 2018. Glyphosate, the active ingredient in Roundup, has been classified by the World Health Organization as a probable human carcinogen since 2015.
'Historic Victory': Bayer to End US Residential Sales of Glyphosate-Based Herbicides
"As agricultural, large-scale use of this toxic pesticide continues, our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."
In a move that environmental groups celebrated as a "historic victory" following years of campaigning to remove Roundup and similar weedkillers from store shelves, Bayer on Thursday announced that it will halt the sale of glyphosate-based herbicides to consumers in the U.S. lawn and garden market by 2023.
"Bayer's decision to end U.S. residential sale[s] of Roundup is a historic victory for public health and the environment," Andrew Kimbrell, executive director of the Center for Food Safety (CFS), said in a statement.
"As agricultural, large-scale use of this toxic pesticide continues," he added, "our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."
While calling the announcement "an important victory to protect the health of Americans," Kendra Klein, senior scientist at Friends of the Earth, stressed that "action on this toxic weedkiller can't wait until 2023. Major home and garden retailers like Home Depot and Lowe's must lead the industry by ending the sales of Roundup immediately."
The key ingredient found in Roundup, the world's most widely used herbicide, is glyphosate. Described by the World Health Organization as "probably carcinogenic," glyphosate poses threats to human health and to pollinators such as bumblebees and monarch butterflies.
Bayer stated that it will switch Roundup and other glyphosate-based weedkillers to formulas that "rely on alternative active ingredients" in order to "manage litigation risk and not because of any safety concerns."
Thursday's decision came in response to several legal battles that Bayer, a German pharmaceutical and biotech corporation, inherited when it acquired Monsanto, a U.S. agrochemical giant and creator of Roundup, in 2018.
Last year, Bayer announced multiple massive settlements totaling more than $11 billion to compensate individuals harmed by two Monsanto herbicides.
In one case, the company agreed to pay $10.9 billion to about 125,000 people who alleged the use of Roundup was to blame for their cancer diagnoses.
The Roundup litigation settlement was preceded by three high-profile lawsuits, in which juries sided with plaintiffs suffering from non-Hodgkin lymphoma "in finding that their exposure to glyphosate contributed to their cancers," CFS explained. "Plaintiffs Edwin Hardeman, DeWayne Johnson, and Alberta and Alva Pilliod were each awarded between $25 to $87 million."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops."
--Kendra Klein, Friends of the Earth
Two months ago, the U.S. Court of Appeals for the 9th Circuit in San Francisco affirmed a lower court ruling in Hardeman v. Monsanto, which found that Monsanto had failed to disclose the dangers glyphosate poses to human health and must be held accountable for the cancer suffered by users of Roundup.
By upholding the previous judgment against Monsanto, Kimbrell said at the time, the court "unanimously rejected Bayer's argument that Mr. Hardeman and thousands of others harmed by their products are prohibited by federal law from suing to redress their injuries."
In a separate settlement last year, Bayer agreed to pay $400 million to thousands of farmers whose crops had been damaged as a result of the widespread drift of Monsanto's dicamba herbicide. That agreement was preceded by two lawsuits that, according to CFS, "likely provided impetus for Bayer to settle."
In California, jury trials over Monsanto's Roundup and dicamba products continue to be held.
Meanwhile, CFS is also currently representing a coalition of farmworkers and environmentalists in a lawsuit that seeks to reverse the Environmental Protection Agency's approval of glyphosate, which was reviewed and registered in January 2020 by Trump administration officials.
While President Joe Biden's EPA admitted in May that the Trump-era assessment of glyphosate was flawed and requires a do-over, the agency failed to provide a deadline for a new decision and argued that Roundup should remain on U.S. shelves in the meantime.
Given that Bayer's decision to stop selling glyphosate-based herbicides by 2023 only applies to consumers in the U.S. lawn and garden market, Klein emphasized that "the battle against this toxic chemical is far from over."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops," she added. "Retailers and regulators must act now to ban this cancer-linked weedkiller."
We are at a crossroads
This country and this world are at a monumental crossroads. US voters have an opportunity to beat back the forces of fascism and confront the billionaires who are rigging the economy, our media system, and our democracy, making it increasingly impossible for ordinary people to get by. We’re not just talking about the election. We’re talking about what must be done once these fascist elements are vanquished from power. We need a bolder set of solutions than what either major party has so far been willing to offer and a working-class movement ready to fight like hell for it. Trump didn't emerge from nowhere. The conditions that fueled MAGA authoritarianism were created by decades of radical neoliberal economic policies and a corrupt political system dominated by corporate interests. They slashed taxes on the super-rich, promising that the benefits would trickle down. They said giveaways to the corporate titans would make life more affordable for the rest of us. It was all bullshit. And when a bitter, betrayed populace searches for someone to blame, right-wing demagogues have little trouble finding scapegoats. People know when they're being lied to, but you won't hear any of this from the corporate media. Only independent journalism—powered and funded by people who believe in building a better world—can deliver truly trustworthy daily news. Our Fall Campaign is underway, and we need your help. To power our newsroom through the rest of the year, we need to raise $125,000 by midnight on October 31. So if you share our vision, please contribute whatever you can to sustain our work. |
In a move that environmental groups celebrated as a "historic victory" following years of campaigning to remove Roundup and similar weedkillers from store shelves, Bayer on Thursday announced that it will halt the sale of glyphosate-based herbicides to consumers in the U.S. lawn and garden market by 2023.
"Bayer's decision to end U.S. residential sale[s] of Roundup is a historic victory for public health and the environment," Andrew Kimbrell, executive director of the Center for Food Safety (CFS), said in a statement.
"As agricultural, large-scale use of this toxic pesticide continues," he added, "our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."
While calling the announcement "an important victory to protect the health of Americans," Kendra Klein, senior scientist at Friends of the Earth, stressed that "action on this toxic weedkiller can't wait until 2023. Major home and garden retailers like Home Depot and Lowe's must lead the industry by ending the sales of Roundup immediately."
The key ingredient found in Roundup, the world's most widely used herbicide, is glyphosate. Described by the World Health Organization as "probably carcinogenic," glyphosate poses threats to human health and to pollinators such as bumblebees and monarch butterflies.
Bayer stated that it will switch Roundup and other glyphosate-based weedkillers to formulas that "rely on alternative active ingredients" in order to "manage litigation risk and not because of any safety concerns."
Thursday's decision came in response to several legal battles that Bayer, a German pharmaceutical and biotech corporation, inherited when it acquired Monsanto, a U.S. agrochemical giant and creator of Roundup, in 2018.
Last year, Bayer announced multiple massive settlements totaling more than $11 billion to compensate individuals harmed by two Monsanto herbicides.
In one case, the company agreed to pay $10.9 billion to about 125,000 people who alleged the use of Roundup was to blame for their cancer diagnoses.
The Roundup litigation settlement was preceded by three high-profile lawsuits, in which juries sided with plaintiffs suffering from non-Hodgkin lymphoma "in finding that their exposure to glyphosate contributed to their cancers," CFS explained. "Plaintiffs Edwin Hardeman, DeWayne Johnson, and Alberta and Alva Pilliod were each awarded between $25 to $87 million."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops."
--Kendra Klein, Friends of the Earth
Two months ago, the U.S. Court of Appeals for the 9th Circuit in San Francisco affirmed a lower court ruling in Hardeman v. Monsanto, which found that Monsanto had failed to disclose the dangers glyphosate poses to human health and must be held accountable for the cancer suffered by users of Roundup.
By upholding the previous judgment against Monsanto, Kimbrell said at the time, the court "unanimously rejected Bayer's argument that Mr. Hardeman and thousands of others harmed by their products are prohibited by federal law from suing to redress their injuries."
In a separate settlement last year, Bayer agreed to pay $400 million to thousands of farmers whose crops had been damaged as a result of the widespread drift of Monsanto's dicamba herbicide. That agreement was preceded by two lawsuits that, according to CFS, "likely provided impetus for Bayer to settle."
In California, jury trials over Monsanto's Roundup and dicamba products continue to be held.
Meanwhile, CFS is also currently representing a coalition of farmworkers and environmentalists in a lawsuit that seeks to reverse the Environmental Protection Agency's approval of glyphosate, which was reviewed and registered in January 2020 by Trump administration officials.
While President Joe Biden's EPA admitted in May that the Trump-era assessment of glyphosate was flawed and requires a do-over, the agency failed to provide a deadline for a new decision and argued that Roundup should remain on U.S. shelves in the meantime.
Given that Bayer's decision to stop selling glyphosate-based herbicides by 2023 only applies to consumers in the U.S. lawn and garden market, Klein emphasized that "the battle against this toxic chemical is far from over."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops," she added. "Retailers and regulators must act now to ban this cancer-linked weedkiller."
- Public Health Group Files 'Groundbreaking' Petition Arguing Glyphosate Is Illegal ›
- 'Outrageous': New Roundup Is 45 Times More Toxic | Common Dreams ›
- Opinion | Don’t Buy Your Loved Ones Toxins for the Holidays | Common Dreams ›
- Trump EPA 'Hitting New Heights of Absurdity' With Plan to Reapprove Pesticide Dicamba | Common Dreams ›
- Journal Finally Retracts Roundup Cancer Study Reliant on Monsanto Research and Ghostwriting | Common Dreams ›
- Citing Child Cancer Risk, Lawsuit Targets Trump EPA Over Glyphosate | Common Dreams ›
In a move that environmental groups celebrated as a "historic victory" following years of campaigning to remove Roundup and similar weedkillers from store shelves, Bayer on Thursday announced that it will halt the sale of glyphosate-based herbicides to consumers in the U.S. lawn and garden market by 2023.
"Bayer's decision to end U.S. residential sale[s] of Roundup is a historic victory for public health and the environment," Andrew Kimbrell, executive director of the Center for Food Safety (CFS), said in a statement.
"As agricultural, large-scale use of this toxic pesticide continues," he added, "our farmworkers remain at risk. It's time for EPA to act and ban glyphosate for all uses."
While calling the announcement "an important victory to protect the health of Americans," Kendra Klein, senior scientist at Friends of the Earth, stressed that "action on this toxic weedkiller can't wait until 2023. Major home and garden retailers like Home Depot and Lowe's must lead the industry by ending the sales of Roundup immediately."
The key ingredient found in Roundup, the world's most widely used herbicide, is glyphosate. Described by the World Health Organization as "probably carcinogenic," glyphosate poses threats to human health and to pollinators such as bumblebees and monarch butterflies.
Bayer stated that it will switch Roundup and other glyphosate-based weedkillers to formulas that "rely on alternative active ingredients" in order to "manage litigation risk and not because of any safety concerns."
Thursday's decision came in response to several legal battles that Bayer, a German pharmaceutical and biotech corporation, inherited when it acquired Monsanto, a U.S. agrochemical giant and creator of Roundup, in 2018.
Last year, Bayer announced multiple massive settlements totaling more than $11 billion to compensate individuals harmed by two Monsanto herbicides.
In one case, the company agreed to pay $10.9 billion to about 125,000 people who alleged the use of Roundup was to blame for their cancer diagnoses.
The Roundup litigation settlement was preceded by three high-profile lawsuits, in which juries sided with plaintiffs suffering from non-Hodgkin lymphoma "in finding that their exposure to glyphosate contributed to their cancers," CFS explained. "Plaintiffs Edwin Hardeman, DeWayne Johnson, and Alberta and Alva Pilliod were each awarded between $25 to $87 million."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops."
--Kendra Klein, Friends of the Earth
Two months ago, the U.S. Court of Appeals for the 9th Circuit in San Francisco affirmed a lower court ruling in Hardeman v. Monsanto, which found that Monsanto had failed to disclose the dangers glyphosate poses to human health and must be held accountable for the cancer suffered by users of Roundup.
By upholding the previous judgment against Monsanto, Kimbrell said at the time, the court "unanimously rejected Bayer's argument that Mr. Hardeman and thousands of others harmed by their products are prohibited by federal law from suing to redress their injuries."
In a separate settlement last year, Bayer agreed to pay $400 million to thousands of farmers whose crops had been damaged as a result of the widespread drift of Monsanto's dicamba herbicide. That agreement was preceded by two lawsuits that, according to CFS, "likely provided impetus for Bayer to settle."
In California, jury trials over Monsanto's Roundup and dicamba products continue to be held.
Meanwhile, CFS is also currently representing a coalition of farmworkers and environmentalists in a lawsuit that seeks to reverse the Environmental Protection Agency's approval of glyphosate, which was reviewed and registered in January 2020 by Trump administration officials.
While President Joe Biden's EPA admitted in May that the Trump-era assessment of glyphosate was flawed and requires a do-over, the agency failed to provide a deadline for a new decision and argued that Roundup should remain on U.S. shelves in the meantime.
Given that Bayer's decision to stop selling glyphosate-based herbicides by 2023 only applies to consumers in the U.S. lawn and garden market, Klein emphasized that "the battle against this toxic chemical is far from over."
"Massive amounts of glyphosate will continue to be sprayed in parks, schools, and on food crops," she added. "Retailers and regulators must act now to ban this cancer-linked weedkiller."
- Public Health Group Files 'Groundbreaking' Petition Arguing Glyphosate Is Illegal ›
- 'Outrageous': New Roundup Is 45 Times More Toxic | Common Dreams ›
- Opinion | Don’t Buy Your Loved Ones Toxins for the Holidays | Common Dreams ›
- Trump EPA 'Hitting New Heights of Absurdity' With Plan to Reapprove Pesticide Dicamba | Common Dreams ›
- Journal Finally Retracts Roundup Cancer Study Reliant on Monsanto Research and Ghostwriting | Common Dreams ›
- Citing Child Cancer Risk, Lawsuit Targets Trump EPA Over Glyphosate | Common Dreams ›